Melissa Angell of Law360 has this coverage of our qui tam case against Allergan: A California federal judge rejected Allergan's bid to dodge a False Claims Act lawsuit Friday, finding the patent attorney behind the suit sufficiently alleged that the pharmaceutical company fraudulently obtained two dementia drug patents to allegedly monopolize pricing and out-compete generics…

Today is the official launch of Lawyerly, a new podcast hosted by Herrera Purdy partner Shawn Kennedy. Lawyerly focuses on telling compelling stories of and about lawyers. The first episode is part of a series we're calling Howrey Doin' Now, in which we catch up with...

American Banker has this coverage of the data privacy class action lawsuit filed by Herrera Purdy against financial technology company Plaid Inc.: Lawsuit against Plaid heightens focus on data privacy issues By Penny Crosman July...

Law360 has this coverage of the Statement of Interest filed by the State of California in support of Herrera Purdy's qui tam action against Allergan: Calif. Backs Patent Atty's Whistleblower Suit Against Allergan California is supporting an attorney who filed a...

Oisin Breen of RIABiz has this coverage of Herrera Purdy's class action privacy suit against Plaid Inc.: 'Fraud' lawsuit slams Plaid on eve of historic $5.3-billion payday; some experts say it's a 'fishing expedition,' but plaintiff's lawyers say, 'This is no...

Lawsuit filed in Northern District of California alleges theft of transactions and other private banking data belonging to tens of millions of consumers . . .

Bloomberg Law has this coverage of our qui tam cases against Allergan, Janssen, and Valeant: Drug companies that allegedly defrauded the government to extend monopolies on brand name drugs face novel legal challenges under the False Claims Act from a patent lawyer who says the cases are a new front in the battle over pricey medications …

Politico has this coverage of Herrera Purdy's Apriso qui tam suit: FALSE CLAIMS SUITS POSE NEW PATENT CHALLENGE PATHWAY — An argument heard in San Francisco Federal District Court earlier this month — and teed up in a similar case in October — could open a new door...

Bloomberg Law has this coverage of our Zytiga qui tam case: A patent attorney is using the False Claims Act to sue brand-name drug companies over extending their patent protections, potentially carving a new legal path for stopping big-brand drugmakers …